Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjen J Cupido

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cardiovascular Research|August 9, 2020
Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trialsArjen J Cupido, John J P Kastelein
Metabolites|January 20, 2022
Gene Therapy Targeting <i>PCSK9</i>Julius L Katzmann, Arjen J Cupido, Ulrich Laufs
Current Opinion in Lipidology|February 9, 2021
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectivesArjen J Cupido, Tycho R Tromp, G Kees Hovingh
Journal of Lipid Research|August 15, 2024
Specific approaches and limitations in (multi)-omic Mendelian randomizationArjen J Cupido, Mingqi Zhou, Aldons J Lusis, et al.
Current Opinion in Lipidology|April 27, 2017
Novel lipid modifying drugs to lower LDL cholesterolArjen J Cupido, Laurens F Reeskamp, John J P Kastelein
Journal of the American Heart Association|June 14, 2022
Low-Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex SpecificArjen J Cupido, Folkert W Asselbergs, A Floriaan Schmidt, et al.
Circulation. Genomic and Precision Medicine|February 1, 2022
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian RandomizationArjen J Cupido, Jordan M Kraaijenhof, Stephen Burgess, et al.
British Journal of Clinical Pharmacology|December 21, 2021
Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6RArjen J Cupido, Folkert W Asselbergs, Pradeep Natarajan, et al.
Journal of Thrombosis and Haemostasis : JTH|September 22, 2023
"C1-inhibitor levels and venous thromboembolism: results from a Mendelian randomization study": replyArjen J Cupido, Remy S Petersen, Amand F Schmidt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 25, 2023
C1-inhibitor levels and venous thromboembolism: results from a Mendelian randomization studyArjen J Cupido, Remy S Petersen, Amand F Schmidt, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cardiovascular Research|August 9, 2020
Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trialsArjen J Cupido, John J P Kastelein
Metabolites|January 20, 2022
Gene Therapy Targeting <i>PCSK9</i>Julius L Katzmann, Arjen J Cupido, Ulrich Laufs
Current Opinion in Lipidology|February 9, 2021
The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectivesArjen J Cupido, Tycho R Tromp, G Kees Hovingh
Journal of Lipid Research|August 15, 2024
Specific approaches and limitations in (multi)-omic Mendelian randomizationArjen J Cupido, Mingqi Zhou, Aldons J Lusis, et al.
Current Opinion in Lipidology|April 27, 2017
Novel lipid modifying drugs to lower LDL cholesterolArjen J Cupido, Laurens F Reeskamp, John J P Kastelein
Journal of the American Heart Association|June 14, 2022
Low-Density Lipoprotein Cholesterol Attributable Cardiovascular Disease Risk Is Sex SpecificArjen J Cupido, Folkert W Asselbergs, A Floriaan Schmidt, et al.
Circulation. Genomic and Precision Medicine|February 1, 2022
Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease: Evidence From Mendelian RandomizationArjen J Cupido, Jordan M Kraaijenhof, Stephen Burgess, et al.
British Journal of Clinical Pharmacology|December 21, 2021
Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6RArjen J Cupido, Folkert W Asselbergs, Pradeep Natarajan, et al.
Journal of Thrombosis and Haemostasis : JTH|September 22, 2023
"C1-inhibitor levels and venous thromboembolism: results from a Mendelian randomization study": replyArjen J Cupido, Remy S Petersen, Amand F Schmidt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 25, 2023
C1-inhibitor levels and venous thromboembolism: results from a Mendelian randomization studyArjen J Cupido, Remy S Petersen, Amand F Schmidt, et al.
Pageof 2